Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Cervical Cancer

  Free Subscription


04.05.2020

1 Acta Biochim Pol
1 Am J Clin Oncol
1 Biochem Biophys Rep
1 Biochem Cell Biol
1 Biomed Res Int
1 BMC Med
1 BMC Public Health
1 BMJ Glob Health
1 Br J Cancer
2 Cancers (Basel)
1 DNA Cell Biol
1 Eur J Pharmacol
1 FEBS Open Bio
1 Front Oncol
1 Heliyon
1 In Vivo
1 Infect Agent Cancer
1 Int J Adolesc Med Health
1 Int J Gynaecol Obstet
10 Int J Gynecol Cancer
1 J Biomed Phys Eng
1 J Immigr Minor Health
1 J Sex Med
1 J Transcult Nurs
1 Medicina (Kaunas)
1 Mol Cancer Res
1 Molecules
1 Oncologist
3 PLoS One
1 Reprod Biol
1 Rofo
1 Technol Cancer Res Treat


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Biochim Pol

  1. CHEN S, Lin R, Hu X, Shi Q, et al
    Naringin induces endoplasmic reticulum stress-mediated apoptosis, inhibits beta-catenin pathway and arrests cell cycle in cervical cancer cells.
    Acta Biochim Pol. 2020 Apr 28. pii: 5182. doi: 10.18388/abp.2020_5182.
    PubMed         Abstract available


    Am J Clin Oncol

  2. VIANI GA, Dos Santos FM, Pavoni JF
    Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities.
    Am J Clin Oncol. 2020;43:52-57.
    PubMed         Abstract available


    Biochem Biophys Rep

  3. ABDUL RAHMAN SF, Muniandy K, Soo YK, Tiew EYH, et al
    Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell lines.
    Biochem Biophys Rep. 2020;22:100756.
    PubMed         Abstract available


    Biochem Cell Biol

  4. WU L, Gong Y, Yan T, Zhang H, et al
    LINP1 Promotes the Progression of Cervical Cancer by Scaffolding EZH2, LSD1 and DNMT1 to Inhibit the Expression of KLF2 and PRSS8.
    Biochem Cell Biol. 2020 Apr 29. doi: 10.1139/bcb-2019-0446.
    PubMed         Abstract available


    Biomed Res Int

  5. PADILLA-MENDOZA JR, Contis-Montes de Oca A, Rodriguez MA, Lopez-Casamichana M, et al
    Protein Phosphorylation in Serine Residues Correlates with Progression from Precancerous Lesions to Cervical Cancer in Mexican Patients.
    Biomed Res Int. 2020;2020:5058928.
    PubMed         Abstract available


    BMC Med

  6. ZHANG S, Zhao F
    Comment on "Will HPV vaccination prevent cervical cancer".
    BMC Med. 2020;18:115.
    PubMed        


    BMC Public Health

  7. TEIXEIRA JC, Vale DB, Braganca JF, Campos CS, et al
    Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
    BMC Public Health. 2020;20:576.
    PubMed         Abstract available


    BMJ Glob Health

  8. PEREZ-GUZMAN PN, Chung MH, De Vuyst H, Dalal S, et al
    The impact of scaling up cervical cancer screening and treatment services among women living with HIV in Kenya: a modelling study.
    BMJ Glob Health. 2020;5:e001886.
    PubMed         Abstract available


    Br J Cancer

  9. JEDY-AGBA E, Joko WY, Liu B, Buziba NG, et al
    Trends in cervical cancer incidence in sub-Saharan Africa.
    Br J Cancer. 2020 Apr 27. pii: 10.1038/s41416-020-0831.
    PubMed         Abstract available


    Cancers (Basel)

  10. GUANI B, Balaya V, Magaud L, Lecuru F, et al
    The Clinical Impact of Low-Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

  11. KLEIN C, Samwel K, Kahesa C, Mwaiselage J, et al
    Mycoplasma Co-Infection Is Associated with Cervical Cancer Risk.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available


    DNA Cell Biol

  12. MEI Y, Jiang P, Shen N, Fu S, et al
    Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer.
    DNA Cell Biol. 2020 Apr 28. doi: 10.1089/dna.2020.5452.
    PubMed         Abstract available


    Eur J Pharmacol

  13. HU Y, Li Y, Huang Y, Jin Z, et al
    METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B.
    Eur J Pharmacol. 2020 Apr 24:173134. doi: 10.1016/j.ejphar.2020.173134.
    PubMed         Abstract available


    FEBS Open Bio

  14. DAI Y, Xie F, Chen Y
    Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability.
    FEBS Open Bio. 2020 Apr 28. doi: 10.1002/2211-5463.12869.
    PubMed         Abstract available


    Front Oncol

  15. CREZEE J, Oei AL, Franken NAP, Stalpers LJA, et al
    Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer.
    Front Oncol. 2020;10:528.
    PubMed        


    Heliyon

  16. PADHY RR, Davidov A, Madrigal L, Alcide G, et al
    Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping.
    Heliyon. 2020;6:e03745.
    PubMed         Abstract available


    In Vivo

  17. CHANDIMALI N, Sun HN, Park YH, Kwon T, et al
    BRM270 Suppresses Cervical Cancer Stem Cell Characteristics and Progression by Inhibiting SOX2.
    In Vivo. 2020;34:1085-1094.
    PubMed         Abstract available


    Infect Agent Cancer

  18. DIOUF D, Diop G, Diarra CAT, Ngom AI, et al
    Systematic screening for cervical cancer in Dakar region: prevalence and correlation with biological and socio-demographic parameters.
    Infect Agent Cancer. 2020;15:24.
    PubMed         Abstract available


    Int J Adolesc Med Health

  19. SHARMA P, Bhilwar M, Tiwari P, Parija PP, et al
    Inadequate awareness of cervical cancer and its prevention among young women of Delhi, India: public health policy implications.
    Int J Adolesc Med Health. 2020.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  20. MUNGO C, Ibrahim S, Bukusi EA, Truong HM, et al
    Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
    Int J Gynaecol Obstet. 2020 Apr 29. doi: 10.1002/ijgo.13171.
    PubMed         Abstract available


    Int J Gynecol Cancer

  21. RAMIREZ PT, Pareja R, Eriksson AGZ, Frumovitz M, et al
    International Gynecologic Cancer Society 2019 meeting summary.
    Int J Gynecol Cancer. 2020;30:167-173.
    PubMed        

  22. LEITAO MM JR
    The aftershocks of the LACC earthquake have begun: brace yourselves.
    Int J Gynecol Cancer. 2020;30:157-159.
    PubMed        

  23. GOROSTIDI M, Lekuona A, Juaristi A, Baiocchi G, et al
    Vaginal carcinoma after cervical dysplasia.
    Int J Gynecol Cancer. 2020;30:265-273.
    PubMed        

  24. GRAU JF, Farinas-Madrid L, Oaknin A
    A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATc
    Int J Gynecol Cancer. 2020;30:139-143.
    PubMed         Abstract available

  25. ALAN M, Gunyeli I, Gultekin M, Sanci M, et al
    Correlation of Swede score colposcopy scoring system and histopathological results in patients with high-risk HPV infection other than HPV16 and 18.
    Int J Gynecol Cancer. 2020;30:35-40.
    PubMed         Abstract available

  26. RICCIARDI E, Plett H, Sangiorgio V, Paderno M, et al
    Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series.
    Int J Gynecol Cancer. 2020;30:21-28.
    PubMed         Abstract available

  27. ORTIZ MOLINA E, Diaz de la Noval B, Rodriguez Suarez MJ, Hernandez Pailos R, et al
    Maylard's incision: how to make an easy incision for complex pelvic abdominal surgery.
    Int J Gynecol Cancer. 2020;30:154-155.
    PubMed        

  28. SEKIYAMA K, Ando Y, Taga A, Kozono Y, et al
    Laparoscopic technique for step-by-step nerve-sparing Okabayashi radical hysterectomy.
    Int J Gynecol Cancer. 2020;30:276-277.
    PubMed        

  29. LI J, Ouyang Y, Tao Y, Wang L, et al
    Small cell carcinoma of the uterine cervix: a multi-institutional experience.
    Int J Gynecol Cancer. 2020;30:174-180.
    PubMed         Abstract available

  30. MARTINEZ-GOMEZ C, Angeles MA, Migliorelli F, Martinez A, et al
    Creation of a Y-shaped ileal orthotopic neobladder after an anterior pelvic exenteration in 10 logical steps.
    Int J Gynecol Cancer. 2020;30:152-153.
    PubMed        


    J Biomed Phys Eng

  31. N S, S A, A S, S S, et al
    Rectal and Bladder Dose Measurements in the Intracavitary Applications of Cervical Cancer Treatment with HDR Afterloading System: Comparison of TPS Data with MOSFET Detector.
    J Biomed Phys Eng. 2020;10:141-146.
    PubMed         Abstract available


    J Immigr Minor Health

  32. ABDI HI, Hoover E, Fagan SE, Adsul P, et al
    Cervical Cancer Screening Among Immigrant and Refugee Women: Scoping-Review and Directions for Future Research.
    J Immigr Minor Health. 2020 Apr 30. pii: 10.1007/s10903-020-01014.
    PubMed         Abstract available


    J Sex Med

  33. DAHL AA, Bentzen AG, Fossa SD, Hess SL, et al
    Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors.
    J Sex Med. 2020 Apr 23. pii: S1743-6095(20)30177.
    PubMed         Abstract available


    J Transcult Nurs

  34. LEE HY, Choi YJ, Shin J, Yoon YJ, et al
    Adherence to Cervical Cancer Screening in Korean American Immigrant Women: Identifying Malleable Variables for Intervention Development.
    J Transcult Nurs. 2020 Apr 27:1043659620914693. doi: 10.1177/1043659620914693.
    PubMed         Abstract available


    Medicina (Kaunas)

  35. PARK WJ, Park JH, Shin HY, Lee JH, et al
    Clinical and Prognostic Significance of TZAP Expression in Cervical Cancer.
    Medicina (Kaunas). 2020;56.
    PubMed         Abstract available


    Mol Cancer Res

  36. CUI X, Wang X, Zhou X, Jia J, et al
    miR-106a regulates cell proliferation and autophagy by targeting LKB1 in HPV-16-associated cervical cancer.
    Mol Cancer Res. 2020 Apr 28. pii: 1541-7786.MCR-19-1114.
    PubMed         Abstract available


    Molecules

  37. ZHANG E, Zhang Y, Fan Z, Cheng L, et al
    Apigenin Inhibits Histamine-Induced Cervical Cancer Tumor Growth by Regulating Estrogen Receptor Expression.
    Molecules. 2020;25.
    PubMed         Abstract available


    Oncologist

  38. ZUSTERZEEL PLM, Aarts JWM, Pol FJM, Ottevanger PB, et al
    Neoadjuvant chemotherapy followed by vaginal radical trachelectomy as fertility preserving treatment for patients with FIGO 2018 stage 1B2 cervical cancer.
    Oncologist. 2020 Apr 27. doi: 10.1634/theoncologist.2020-0063.
    PubMed         Abstract available


    PLoS One

  39. DUAN L, Du H, Wang C, Huang X, et al
    The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
    PLoS One. 2020;15:e0232117.
    PubMed         Abstract available

  40. AMPOFO AG, Adumatta AD, Owusu E, Awuviry-Newton K, et al
    A cross-sectional study of barriers to cervical cancer screening uptake in Ghana: An application of the health belief model.
    PLoS One. 2020;15:e0231459.
    PubMed         Abstract available

  41. ONGTENGCO N, Thiam H, Collins Z, De Jesus EL, et al
    Role of gender in perspectives of discrimination, stigma, and attitudes relative to cervical cancer in rural Senegal.
    PLoS One. 2020;15:e0232291.
    PubMed         Abstract available


    Reprod Biol

  42. ZHANG XY, Ma H, Li J, Lu XR, et al
    Functional implications of miR-145/RCAN3 axis in the progression of cervical cancer.
    Reprod Biol. 2020 Apr 25. pii: S1642-431X(19)30452.
    PubMed         Abstract available


    Rofo

  43. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Rofo. 2020 Apr 30. doi: 10.1055/a-1100-0127.
    PubMed         Abstract available


    Technol Cancer Res Treat

  44. RUAN F, Wang YF, Chai Y
    Diagnostic Values of miR-21, miR-124, and M-CSF in Patients With Early Cervical Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820914983.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: